NY-REN-50 antigen Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-83299
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
1 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of human NY-REN-50 antigen. Peptide sequence: KMCQDYLSSSGLCSQETLEINNDKVAESLGITEFLRKKEIHPDNLGPKHL The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for NY-REN-50 antigen Antibody
![Western Blot: NY-REN-50 antigen Antibody [NBP2-83299]](https://resources.bio-techne.com/images/products/NY-REN-50-antigen-Antibody-Western-Blot-NBP2-83299-img0001.jpg "Western Blot: NY-REN-50 antigen Antibody [NBP2-83299]")
Western Blot: NY-REN-50 antigen Antibody [NBP2-83299]
Western Blot: NY-REN-50 antigen Antibody [NBP2-83299] - WB Suggested Anti-C14ORF131 Antibody Titration: 0.3-0.5ug/ml. Positive Control: HepG2 cell lysateZNF839 is supported by BioGPS gene expression data to be expressed in HepG2Applications for NY-REN-50 antigen Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: NY-REN-50 antigen
Alternate Names
C14orf131, chromosome 14 open reading frame 131, FLJ11132, Renal carcinoma antigen NY-REN-50, zinc finger protein 839
Gene Symbol
ZNF839
Additional NY-REN-50 antigen Products
Product Specific Notices for NY-REN-50 antigen Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...